help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nehrbass, D.
Right arrow Articles by Bannasch, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nehrbass, D.
Right arrow Articles by Bannasch, P.

American Journal of Pathology, Vol 152, 341-345, Copyright © 1998 by American Society for Investigative Pathology


REGULAR ARTICLES

Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis

D Nehrbass, F Klimek and P Bannasch
Abteilung fur Cytopathologie, Deutsches Krebsforschungszentrum Im Neuenheimer Feld, Heidelberg, Germany.

Insulin receptor substrate-1 (IRS-1) is a multisite docking protein occupying a central position in signaling cascades stimulated by a number of growth factors including insulin. Using Western blotting and immunohistochemistry, we investigated the expression of IRS-1 in more than 400 preneoplastic foci of altered hepatocytes and in 12 hepatocellular carcinomas induced in rats by oral administration of N- nitrosomorpholine. In both N-nitrosomorpholine-treated and untreated rat livers, IRS-1 was demonstrable by Western blotting, but with the exception of a few single hepatocytes it was not detectable in the normal parenchyma by immunohistochemistry. In contrast, immunohistochemistry revealed that IRS-1 was strongly expressed in the majority of foci of altered hepatocytes particularly in approximately 97% of the clear/acidophilic and mixed cell foci showing excessive storage of glycogen (glycogenosis). In glycogen-poor basophilic foci of altered hepatocytes and hepatocellular carcinomas, IRS-1 was not detected by immunohistochemistry, but a weak expression was observed in small subpopulations of three hepatocellular carcinomas containing remnants of glycogen. These results indicate that the focal overexpression of IRS-1 is an early event in hepatocarcinogenesis, which is closely correlated with preneoplastic hepatic glycogenosis. During progression from glycogenotic foci to hepatocellular carcinomas, IRS-1-overexpression is gradually down-regulated, and this late event is associated with a fundamental metabolic shift leading to the malignant neoplastic phenotype.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. K. Dearth, X. Cui, H.-J. Kim, I. Kuiatse, N. A. Lawrence, X. Zhang, J. Divisova, O. L. Britton, S. Mohsin, D. C. Allred, et al.
Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2
Mol. Cell. Biol., December 15, 2006; 26(24): 9302 - 9314.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Dombrowski, C. Mathieu, and M. Evert
Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats
Cancer Res., February 1, 2006; 66(3): 1833 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Boissan, E. Beurel, D. Wendum, C. Rey, Y. Lecluse, C. Housset, M.-L. Lacombe, and C. Desbois-Mouthon
Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular Carcinoma
Am. J. Pathol., September 1, 2005; 167(3): 869 - 877.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Dombrowski, C. M. Jost, S. Manekeller, and M. Evert
Cocarcinogenic Effects of Islet Hormones and N-Nitrosomorpholine in Hepatocarcinogenesis after Intrahepatic Transplantation of Pancreatic Islets in Streptozotocin-Diabetic Rats
Cancer Res., August 1, 2005; 65(15): 7013 - 7022.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Evert, J. Sun, S. Pichler, N. Slavova, R. Schneider-Stock, and F. Dombrowski
Insulin Receptor, Insulin Receptor Substrate-1, Raf-1, and Mek-1 during Hormonal Hepatocarcinogenesis by Intrahepatic Pancreatic Islet Transplantation in Diabetic Rats
Cancer Res., November 1, 2004; 64(21): 8093 - 8100.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. Mayer, K. Forstner, and K. Kopplow
Induction and Modulation of Hepatic Preneoplasia and Neoplasia in the Rat by Dehydroepiandrosterone
Toxicol Pathol, January 1, 2003; 31(1): 103 - 112.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
Qin Su and P. Bannasch
Relevance of Hepatic Preneoplasia for Human Hepatocarcinogenesis
Toxicol Pathol, January 1, 2003; 31(1): 126 - 133.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Lassak, L. Del Valle, F. Peruzzi, J. Y. Wang, S. Enam, S. Croul, K. Khalili, and K. Reiss
Insulin Receptor Substrate 1 Translocation to the Nucleus by the Human JC Virus T-antigen
J. Biol. Chem., May 3, 2002; 277(19): 17231 - 17238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.